Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

U.S. Officials: The More We Learn about Zika, the Scarier It Is

By LAURAN NEERGAARD, AP Medical Writer | April 12, 2016

WASHINGTON (AP) — The more researchers learn about the Zika virus, the scarier it appears, federal health officials said Monday as they urged more money for mosquito control and to develop vaccines and treatments.

Scientists increasingly believe the Zika virus sweeping through Latin America and the Caribbean causes devastating defects in fetal brains if women become infected during pregnancy.

“Everything we look at with this virus seems to be a bit scarier than we initially thought,” Dr. Anne Schuchat of the Centers for Disease Control and Prevention said at a White House briefing.

And while experts don’t expect widespread outbreaks in the continental U.S., “we absolutely need to be ready,” she said.

President Barack Obama has sought about $1.9 billion in emergency money to help fight the Zika epidemic internationally and to prepare in case the virus spreads here, but the request has stalled in the GOP-controlled Congress. Last week, the administration said it would use $589 million in funds left over from the Ebola outbreak for some of that work.

But that “is not enough for us to get the job done,” said Dr. Anthony Fauci of the National Institutes of Health, whose agency hopes to have a possible vaccine ready for first-stage safety testing in early fall. “It’s just a temporary stopgap.”

Zika was long considered a nuisance virus, causing only mild symptoms, if any, in most people. But starting with reports from Brazil, over the last year infections in pregnant women have been strongly linked to babies born with unusually small heads, a birth defect called microcephaly that can signal underlying brain damage.

“I’m not an alarmist,” Fauci said, but he and Schuchat cited growing reason for concern about Zika:

  • Researchers also have linked Zika to stillbirths, miscarriages, eye problems, and other complications, with complications not only in the first trimester but throughout pregnancy.
  • Brazilian researchers reported Sunday that Zika preferentially targets developing brain cells. They used stem cells to study embryonic brain development in lab dish, and reported in the journal Science that virus taken from a Brazilian patient destroyed the growing neural cells in a few days.
  • There’s also evidence that some adults occasionally may suffer serious effects from Zika. Researchers already were studying whether Guillain-Barre syndrome, a nerve condition that can cause paralysis, is linked to Zika. And Sunday, another Brazilian research team reported two Zika patients who suffered yet another problem, a brain inflammation that damages the coating of nerve cells in a way similar to multiple sclerosis.

The CDC has warned women who are pregnant or attempting to conceive to avoid travel to Zika-affected areas. Because Zika sometimes spreads through sexual intercourse, the CDC also says men who’ve traveled to Zika-affected areas either should use condoms with their pregnant partners or avoid sex until the baby’s born.

More than 300 travel-associated cases of Zika have been reported in the U.S. so far, and the CDC also wants travelers to take extra steps to avoid being bitten by mosquitoes when they come home—so local insects won’t pick up the virus and spread it. While CDC does expect some clusters of homegrown Zika to occur, it is working with state and local governments to boost mosquito control.

In addition to research into a possible vaccine, Fauci said the NIH is screening medications in the quest for a treatment. A few—15 of 62 screened so far—show some degree of possible activity against Zika in laboratory tests although “that doesn’t mean they’re going to turn out to be good drugs,” he cautioned.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE